AnaptysBio, Inc., a clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States. The company's products include Rosnilimab, a selective pathogenic T cell deplete which completed a Phase 2b trial for the treatment...
23 insider purchases on record · latest filing 2025-01-02.
Insiders have also filed 139 sale transactions at ANAB.